본문 바로가기
KERD
논문KCI 등재

Authors’ Reply: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study

0

조회

0

다운로드

0

인용

0

참고문헌

관련 논문AI추천

Letter to the Editor: Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort studyZhou Zhanyi한국역학회 · Epidemiology and Health2025 · 제47권 Safety of combination therapy of azilsartan medoxomil and amlodipine: a population-based cohort study홍빈, Bea Sungho, Chang Zoe Chi-Jui, Cheng Michael Chun-Yuan, Jeong Han Eol, Jung Kyungyeon, Lai Edward Chia-Cheng, Lee Hyesung, Lee Jong-Young, Su Chris Tzu-Ting한국역학회 · Epidemiology and Health2025 · 제47권 Response to comment on “Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea”주민숙, Eunjung Park, Young Lee대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제4호Comment on “Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea”Anton Pottegård, Daniel Morales대한내과학회 · The Korean Journal of Internal Medicine2020 · 제35권 제4호Real-world efficacy of fimasartan vs. other angiotensin receptor blockers in combination with calcium channel blockers: a nationwide cohort studyHan Kyung-Do, Kim Bongseong, Kim Hyung-Kwan, Kim Yong-Jin, Lee Heesun, Lee Huijin, Park Chan Soon, Rhee Tae-Min대한고혈압학회 · Clinical Hypertension2024 · 제30권 Response to the letter regarding article, “The impact of renin-angiotensin system inhibitors on colorectal neoplasm development”Choi Ji Min, Choi Su-Yeon, Han Yoo Min, Lee Heesun, Rhee Tae-Min대한고혈압학회 · Clinical Hypertension2025 · 제31권

이 간행물의 다른 논문 (75건)